Clinical predictors of early infarct-related artery patency following thrombolytic therapy: Importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: The GUSTO-I experience

被引:57
作者
Lundergan, CF
Reiner, JS
McCarthy, WF
Coyne, KS
Califf, RM
Ross, AM
机构
[1] George Washington Univ, Med Ctr, Cardiovasc Res Inst, Washington, DC 20037 USA
[2] George Washington Univ, GUSTO 1 Core Angiog Lab, Washington, DC 20037 USA
[3] Duke Univ, Durham, NC USA
关键词
D O I
10.1016/S0735-1097(98)00278-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The purpose of this study was to determine patient characteristics that are a priori predictors of early infarct related artery patency following thrombolytic therapy, and to provide a paradigm which may identify patients who would be most likely to achieve restoration of normal (TIMI 3) coronary flow in response to thrombolytic therapy. Background. Restoration of infarct-related artery perfusion in acute myocardial infarction is necessary for preservation of ventricular function and mortality reduction. Clinical variables that are a priori predictors of early patency with currently available thrombolytic regimens have not been fully characterized. Methods. The probability of early infarct-related artery patency (TIMI 3 flow) was determined by multivariable logistic regression. We determined a reduced (parsimonious) model for predicting early (90 min) infarct-related artery patency (TIMI grade 3) based on data from 1,030 patients in the GUSTO-I Angiographic study. Results. Predictors of 90 min TIMI 3 how are use of an accelerated t-PA regimen (vs. streptokinase containing regimens) (chi(2) = 39.1; p less than or equal to 0.0001), infarct related artery (RCA/Lcx vs. LAD) (chi(2) = 12.7; p = 0.0004), body weight (chi(2) = 10.3; p = 0.001) and history of smoking (chi(2) = 7.4; p = 0.007). Time from symptom onset to treatment was not significant (p = 0.71). Conclusions. The efficacy of currently available thrombolytic regimens is chiefly dependent on choice of thrombolytic regimen, body weight, infarct-related coronary artery and smoking history. Clinical variables alone correctly predict a priori TIMI 3 flow in the infarct-related artery 64% of the time. Patients with body weights greater than 85 kg are at a significant disadvantage with regard to achieving successful thrombolysis compared to those with lesser body weights. (J Am Coil Cardiol 1998;32:641-7) (C) 1998 by the American College of Cardiology.
引用
收藏
页码:641 / 647
页数:7
相关论文
共 28 条
[1]   MULTICENTER REPERFUSION TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - CONTROLLED COMPARISON WITH INTRACORONARY STREPTOKINASE [J].
ANDERSON, JL ;
ROTHBARD, RL ;
HACKWORTHY, RA ;
SORENSEN, SG ;
FITZPATRICK, PG ;
DAHL, CF ;
HAGAN, AD ;
BROWNE, KF ;
SYMKOVIAK, GP ;
MENLOVE, RL ;
BARRY, WH ;
ECKERSON, HW ;
MARDER, VJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 11 (06) :1153-1163
[2]   MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
ANDERSON, JL ;
SORENSEN, SG ;
MORENO, FL ;
HACKWORTHY, RA ;
BROWNE, KF ;
DALE, HT ;
LEYA, F ;
DANGOISSE, V ;
ECKERSON, HW ;
MARDER, VJ .
CIRCULATION, 1991, 83 (01) :126-140
[3]  
[Anonymous], STAT METHODS
[4]   EVALUATION OF PARADOXIC BENEFICIAL-EFFECTS OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - MECHANISM OF THE SMOKERS PARADOX FROM THE GUSTO-I TRIAL, WITH ANGIOGRAPHIC INSIGHTS [J].
BARBASH, GI ;
REINER, J ;
WHITE, HD ;
WILCOX, RG ;
ARMSTRONG, PW ;
SADOWSKI, Z ;
MORRIS, D ;
AYLWARD, P ;
WOODLIEF, LH ;
TOPOL, EJ ;
CALIFF, RM ;
ROSS, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1222-1229
[5]   THROMBOLYSIS AND ANGIOPLASTY IN MYOCARDIAL-INFARCTION (TAMI-1) TRIAL - INFLUENCE OF INFARCT LOCATION ON ARTERIAL PATENCY, LEFT-VENTRICULAR FUNCTION AND MORTALITY [J].
BATES, ER ;
CALIFF, RM ;
STACK, RS ;
ARONSON, L ;
GEORGE, BS ;
CANDELA, RJ ;
KEREIAKES, DJ ;
ABBOTTSMITH, CW ;
ANDERSON, L ;
PITT, B ;
ONEILL, WW ;
TOPOL, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (01) :12-18
[7]   Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (Recombinant plasminogen activator) and front-loaded, accelerated alteplase (Recombinant tissue plasminogen activator) in patients with acute myocardial infarction [J].
Bode, C ;
Smalling, RW ;
Berg, G ;
Burnett, C ;
Lorch, G ;
Kalbfleisch, JM ;
Chernoff, R ;
Christie, LG ;
Feldman, RL ;
Seals, AA ;
Weaver, WD .
CIRCULATION, 1996, 94 (05) :891-898
[8]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[9]  
Freund R.J., 1991, SAS SYSTEM REGRESSIO
[10]   EFFECT OF CIGARETTE-SMOKING ON CORONARY PATENCY AFTER THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION [J].
GOMEZ, MA ;
KARAGOUNIS, LA ;
ALLEN, A ;
ANDERSON, JL ;
BROWNE, KF ;
DANGOISSE, V ;
LEYA, F ;
LYONS, RM ;
DALE, HT ;
WATSON, LE ;
SYMKOVIAK, GP ;
FITZPATRICK, P ;
HAGAN, AD ;
CHRISTIE, LG ;
MILLER, RH ;
ASKINS, JC ;
STRINGER, KA ;
DAHL, CF ;
HALL, SM ;
ABRAMS, J ;
MONRAD, ES ;
BOVE, AA ;
KOSINSKI, EJ ;
MORCH, JE ;
FALCONE, W ;
BARRY, WH ;
RATHBUN, JD ;
SMITH, WB ;
LACH, RD ;
SINGH, JB .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (05) :373-378